TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3933102

Group type: EXPERIMENTAL
Intervention: Tocainide (250 mg, single i.v. dose)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lidocaine (100 mg, single i.v. dose)
Number of subjects: 10
Study: 28829923

Group type: EXPERIMENTAL
Intervention: High dairy intake (1500 mg calcium/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Low dairy intake (600 mg calcium/day)
Number of subjects: 80
Study: 26460572

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT; Coping cat program)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (sertraline)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Combination of CBT and sertraline
Number of subjects: 488

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 488
Study: 25215530

Group type: EXPERIMENTAL
Intervention: Higher serum 25(OH)D concentrations in women
Number of subjects: 5010

Group type: EXPERIMENTAL
Intervention: Higher serum 25(OH)D concentrations in men
Number of subjects: 5010
Study: 22829794

Group type: EXPERIMENTAL
Intervention: Gain-framed appeals
Number of subjects: 4168

Group type: COMPARATOR
Intervention: Loss-framed appeals
Number of subjects: 4168
Study: 19780844

Group type: EXPERIMENTAL
Intervention: Denture adhesive used for 14 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no denture adhesive)
Number of subjects: 24
Study: 18364139

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 16103468

Group type: EXPERIMENTAL
Intervention: Warfarin plus aspirin
Number of subjects: 5938

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 5938
Study: 12552048

Group type: EXPERIMENTAL
Intervention: Topical anesthetic applied on the contralateral forearm and foot
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Nerve function measurements (neuropathy disability score)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Nerve function measurements (vibration perception threshold)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Nerve function measurements (Semmes-Weinstein monofilament perception)
Number of subjects: 33
Study: 10227572

Group type: EXPERIMENTAL
Intervention: HCV screening using standard techniques
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: History of previous transfusion
Number of subjects: 423
Study: 8766067

Group type: EXPERIMENTAL
Intervention: 0.15 mg clonidine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 1822319

Group type: EXPERIMENTAL
Intervention: Zuclopenthixol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 15
Study: 7037325

Group type: EXPERIMENTAL
Intervention: Prophylactic methicillin
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 30760204

Group type: EXPERIMENTAL
Intervention: SENATOR software intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard routine pharmaceutical clinical care
Number of subjects: 0
Study: 29465568

Group type: EXPERIMENTAL
Intervention: Listening to water sounds
Number of subjects: 60

Group type: COMPARATOR
Intervention: Relaxing piece of music
Number of subjects: 60

Group type: COMPARATOR
Intervention: No auditory stimulus
Number of subjects: 60
Study: 26047827

Group type: EXPERIMENTAL
Intervention: Placebo pill
Number of subjects: 54

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 54
Study: 25193424

Group type: EXPERIMENTAL
Intervention: Online support tool (CHESS)
Number of subjects: 130

Group type: COMPARATOR
Intervention: List of five commonly used Internet sites (comparison group)
Number of subjects: 130
Study: 22460966

Group type: EXPERIMENTAL
Intervention: 0.5 g of valacyclovir twice daily for 1 year after initial treatment with 1 g of valacyclovir 3 times daily for 1 week
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 20228387

Group type: EXPERIMENTAL
Intervention: Dyspnoea relief
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Treatment success
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Moderate or marked improvement in dyspnoea
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Dyspnoea relief and treatment success
Number of subjects: 303
Study: 18005588

Group type: EXPERIMENTAL
Intervention: Group A (mean blood glucose 4.4 - 6.1 mmol/L)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Group B (mean blood glucose 6.7 - 8.3 mmol/L)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Group C (mean blood glucose 10.0 - 11.1 mmol/L)
Number of subjects: 188
Study: 16153516

Group type: EXPERIMENTAL
Intervention: ASD-D (atrial septal defect device closure) group
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: ASD-S (atrial septal defect surgical closure) group
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 11936456

Group type: EXPERIMENTAL
Intervention: Bone scintigraphy using technetium diphosphonate 99 mTc
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bone scintigraphy
Number of subjects: 30
Study: 10649937

Group type: EXPERIMENTAL
Intervention: Rotary toothbrush (Rota-dent)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sonic toothbrush (Sonicare)
Number of subjects: 40
Study: 8678619

Group type: EXPERIMENTAL
Intervention: Colonic J pouch anastomosis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Straight anastomosis
Number of subjects: 100
Study: 1852517

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol (200 micrograms, tidal breathing)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol (200 micrograms, tidal breathing) after carbachol bronchial challenge
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo (phosphate-buffered saline)
Number of subjects: 88
Study: 6338997

Group type: EXPERIMENTAL
Intervention: Topical acyclovir ointment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 40
Study: 31025397

Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 64

Group type: COMPARATOR
Intervention: TENS
Number of subjects: 64
Study: 29185897

Group type: EXPERIMENTAL
Intervention: Psychotropic medication with hypnotic effect (specific medications include mirtazapine and clotiapine)
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Mirtazapine and clotiapine (hypnotic treatments)
Number of subjects: 481
Study: 26902366

Group type: EXPERIMENTAL
Intervention: GSD-GYN-C plus usual care (UC)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Usual care (UC) alone
Number of subjects: 165
Study: 25242076

Group type: EXPERIMENTAL
Intervention: Two-layer compression hosiery (HH)
Number of subjects: 457

Group type: COMPARATOR
Intervention: Four-layer bandage (4LB)
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Two-layer bandage (2LB)
Number of subjects: 457
Study: 22807523

Group type: EXPERIMENTAL
Intervention: RBV induction (2000 mg/d) plus erythropoietin β (450 IU/kg/wk)
Number of subjects: 357

Group type: COMPARATOR
Intervention: RBV standard dosing (1000 or 1200 mg/d)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: RBV induction plus erythropoietin
Number of subjects: 357

Group type: COMPARATOR
Intervention: RBV standard dosing
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 357
Study: 21162963

Group type: EXPERIMENTAL
Intervention: Recruitment Maneuver (RM) group
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110
Study: 17933159

Group type: COMPARATOR
Intervention: EMLA cream
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Myolaxin ointment
Number of subjects: 60
Study: 16244513

Group type: EXPERIMENTAL
Intervention: Joint admission of children (21 mothers)
Number of subjects: 43

Group type: COMPARATOR
Intervention: No joint admission of children (22 mothers)
Number of subjects: 43
Study: 12148914

Group type: EXPERIMENTAL
Intervention: Intervention program to enhance knowledge and self-efficacy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 0
Study: 11232606

Group type: EXPERIMENTAL
Intervention: Time from cardioversion to first episode recurrence
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Cross-over design
Number of subjects: 134
Study: 9884845

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 58
Study: 7987906

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine mouthrinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phenolic mouthrinse
Number of subjects: 0
Study: 2688037

Group type: EXPERIMENTAL
Intervention: Trimipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study: 1060356

Group type: EXPERIMENTAL
Intervention: Paracervical block (PCB) with adrenaline
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Paracervical block (PCB) without adrenaline
Number of subjects: 52

Group type: COMPARATOR
Intervention: Epidural block
Number of subjects: 52
Study: 7435798

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg orally once a week)
Number of subjects: 1125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1125

Group type: COMPARATOR
Intervention: Doxycycline and Placebo
Number of subjects: 1125
Study: 31707826

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study: 30280648

Group type: EXPERIMENTAL
Intervention: Standard-use group
Number of subjects: 1406

Group type: COMPARATOR
Intervention: Broader-use group
Number of subjects: 1406
Study: 27241671

Group type: EXPERIMENTAL
Intervention: Chewing gum with CPP-ACP (PI)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Chewing gum without CPP-ACP (PII)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control phase (salivary effect without stimulation, PIII)
Number of subjects: 19
Study: 25313574

Group type: EXPERIMENTAL
Intervention: Dietary fructo-oligosaccharide (FOS) supplementation (0, 1, 2 and 3%)
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Dietary fructo-oligosaccharide (FOS) supplementation (2 and 3%)
Number of subjects: 323
Study: 22500383

Group type: EXPERIMENTAL
Intervention: Guilin Watermelon Frost (GWF) local spray
Number of subjects: 160

Group type: COMPARATOR
Intervention: bFGF-collagen sponge (Control)
Number of subjects: 160
Study: 19967420

Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC) 1,800 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Epigallocatechin gallate (EGCG) 1,800 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (fiber - glucomannan) 1,000 mg
Number of subjects: 30
Study: 18008241

Group type: EXPERIMENTAL
Intervention: Monthly IPTp (sulfadoxine-pyrimethamine)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Standard 2-dose IPTp (sulfadoxine-pyrimethamine)
Number of subjects: 456
Study: 16247737

Group type: EXPERIMENTAL
Intervention: 700 mg glycine sublingually
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12219187

Group type: EXPERIMENTAL
Intervention: Plant sterol ester (PSE) treatment (2.8g/d = 1.68 phytosterols)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (no treatment)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Margarine (20g/d)
Number of subjects: 60
Study: 10526342

Group type: EXPERIMENTAL
Intervention: Visual attention modulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Equivalent motion energy measurement
Number of subjects: 0
Study: 8576675

Group type: EXPERIMENTAL
Intervention: Clinacanthus nutans extract applied five times daily for 7-14 days
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Clinacanthus nutans extract
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 1840336

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnesium lactate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate combined with cinnarizine
Number of subjects: 0
Study: 7100261

Group type: EXPERIMENTAL
Intervention: Nomifensine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study: 30932133

Group type: EXPERIMENTAL
Intervention: RJ group (BCAA-enriched nutritional supplements, 2500 mg BCAA and 20 IU vitamin D, twice a day until hospital discharge)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: RJ group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 29781649

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy augmented by a relational focus (CBT‐R)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Graduated exposure‐applied relaxation (GEAR)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Wait list (WL) control
Number of subjects: 100
Study: 27817813

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol Easyhaler (320/9 μg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol Easyhaler (1280/36 μg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Symbicort Turbuhaler (320/9 μg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Symbicort Turbuhaler (1280/36 μg)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol Easyhaler and Symbicort Turbuhaler
Number of subjects: 72
Study: 24856796

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 46
Study: 22253903

Group type: EXPERIMENTAL
Intervention: Anakinra (IL-1 receptor antagonist)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 20606660

Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitor (PPI) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Withdrawal of PPI
Number of subjects: 0
Study: 17389561

Group type: EXPERIMENTAL
Intervention: Second-generation electrically heated cigarette smoking system (EHCSS)
Number of subjects: 100
Study: 16310604

Group type: EXPERIMENTAL
Intervention: Clinical examination for signs of DVT using method 1 (DVT Risk Stratification System)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Clinical examination for signs of DVT using method 2 (DVT Risk Score)
Number of subjects: 239
Study: 12032522

Group type: EXPERIMENTAL
Intervention: DTO and phenobarbital
Number of subjects: 20

Group type: COMPARATOR
Intervention: DTO alone
Number of subjects: 20
Study: 10396200

Group type: EXPERIMENTAL
Intervention: Anterior transposition
Number of subjects: 20

Group type: COMPARATOR
Intervention: Myectomy
Number of subjects: 20
Study: 7745514

Group type: EXPERIMENTAL
Intervention: Synthetic surfactant
Number of subjects: 419

Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 419
Study: 2248842

Group type: EXPERIMENTAL
Intervention: 2% lignocaine
Number of subjects: 8

Group type: COMPARATOR
Intervention: 0.9% sodium chloride solution (control)
Number of subjects: 8
Study: 760746

Group type: EXPERIMENTAL
Intervention: Intravenous propantheline bromide (15 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral propantheline bromide (15 mg)
Number of subjects: 6
Study: 30827722

Group type: EXPERIMENTAL
Intervention: Arabinoxylan oligosaccharides (AXOS) 10.4 g/d
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Polyunsaturated fatty acids (PUFA) 3.6 g/d n-3 PUFA
Number of subjects: 27
Study: 29873077

Group type: EXPERIMENTAL
Intervention: Total red meat intake (50 g/1,000 kcal increase)
Number of subjects: 407270

Group type: EXPERIMENTAL
Intervention: Unprocessed red meat intake
Number of subjects: 407270

Group type: EXPERIMENTAL
Intervention: White meat intake (50 g/1,000 kcal increase)
Number of subjects: 407270

Group type: EXPERIMENTAL
Intervention: Heme iron (highest quintile)
Number of subjects: 407270

Group type: EXPERIMENTAL
Intervention: HCAs (highest quintile)
Number of subjects: 407270

Group type: EXPERIMENTAL
Intervention: Nitrate/nitrite (highest quintile)
Number of subjects: 407270
Study: 26496016

Group type: EXPERIMENTAL
Intervention: Olanzapine+Sertraline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olanzapine+Placebo
Number of subjects: 0
Study: 25171998

Group type: EXPERIMENTAL
Intervention: HPPTUS-9
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: HPPTUS-5
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional US
Number of subjects: 24
Study: 22499288

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 9193

Group type: COMPARATOR
Intervention: Atenolol-based treatment
Number of subjects: 9193

Group type: EXPERIMENTAL
Intervention: Losartan and Atenolol-based treatment
Number of subjects: 9193
Study: 20614049

Group type: COMPARATOR
Intervention: Atraumatic extraction (group A, n = 101 extraction sites)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Atraumatic extraction sealing the socket with autogenous soft tissue graft (group B, n = 39)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Atraumatic extraction with socket seal surgery and collagen matrix impregnated with gentamicin (group C, n = 33)
Number of subjects: 125
Study: 18525300

Group type: EXPERIMENTAL
Intervention: Pd-103 implantation with 90 Gy
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Pd-103 implantation with 115 Gy
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: 44 Gy preimplant supplemental beam radiation
Number of subjects: 568

Group type: COMPARATOR
Intervention: 20 Gy preimplant supplemental beam radiation
Number of subjects: 568
Study: 16044063

Group type: EXPERIMENTAL
Intervention: office-based vision therapy/orthoptics
Number of subjects: 46

Group type: COMPARATOR
Intervention: office-based placebo vision therapy/orthoptics
Number of subjects: 46

Group type: COMPARATOR
Intervention: home-based pencil pushups
Number of subjects: 46
Study: 12014591

Group type: EXPERIMENTAL
Intervention: PEA‐BP
Number of subjects: 268

Group type: COMPARATOR
Intervention: ADHD
Number of subjects: 268

Group type: COMPARATOR
Intervention: CC
Number of subjects: 268
Study: 9915532

Group type: EXPERIMENTAL
Intervention: 24-hour NGT removal (study group)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Clinical signs of return of bowel function (control group)
Number of subjects: 175
Study: 7751409

Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMI) and Fluoxetine (FLU) combination
Number of subjects: 15

Group type: COMPARATOR
Intervention: Amitriptyline (AMI) alone
Number of subjects: 15
Study: 2209270

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (31.5 Gy in 3.5 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no preoperative radiotherapy)
Number of subjects: 0
Study: 6106110

Group type: EXPERIMENTAL
Intervention: Premedication with diazepam before endoscopy with a narrow instrument (9 mm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endoscopy with a larger instrument (13 mm) after diazepam sedation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Upper gastrointestinal endoscopy without sedation using a small diameter instrument (9 mm)
Number of subjects: 0
Study: 31152309

Group type: EXPERIMENTAL
Intervention: Nigella sativa (NS) oil capsules (1350 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin tablets
Number of subjects: 0
Study: 28826745

Group type: EXPERIMENTAL
Intervention: Continuous infusion of 0.5% ropivacaine for 96 hours
Number of subjects: 75

Group type: COMPARATOR
Intervention: Sham infusion (normal saline) for 96 hours
Number of subjects: 75

Group type: COMPARATOR
Intervention: Usual care (no device)
Number of subjects: 75
Study: 25351453

Group type: EXPERIMENTAL
Intervention: Glutamine (10 g 3 times a day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23988855

Group type: EXPERIMENTAL
Intervention: α-Lipoic acid (ALA) treatment for 2 days (600 mg orally three times a day before and after coronary catheterization, n = 100)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (n = 102)
Number of subjects: 202
Study: 21481742

Group type: EXPERIMENTAL
Intervention: Rufinamide (up to 45 mg/kg daily) as adjunctive therapy
Number of subjects: 918

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 918
Study: 19686530

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Extended treatment with varenicline
Number of subjects: 1208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1208
Study: 16378696

Group type: EXPERIMENTAL
Intervention: Reactive hypoglycemia (RH) group
Number of subjects: 46

Group type: COMPARATOR
Intervention: Non-reactive hypoglycemia (non-RH) group
Number of subjects: 46
Study: 15304151

Group type: EXPERIMENTAL
Intervention: ABMK treatment (Agaricus blazei Murill Kyowa)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nontreated placebo group
Number of subjects: 100
Study: 11300443

Group type: EXPERIMENTAL
Intervention: RADIUS self-expanding stent
Number of subjects: 62

Group type: COMPARATOR
Intervention: Palmaz-Schatz balloon-expandable stent
Number of subjects: 62
Study: 9027671

Group type: EXPERIMENTAL
Intervention: Dirithromycin for 5 days
Number of subjects: 334

Group type: COMPARATOR
Intervention: Amoxiclav for 7-10 days
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Dirithromycin
Number of subjects: 334

Group type: COMPARATOR
Intervention: Amoxiclav
Number of subjects: 334
Study: 8282361

Group type: EXPERIMENTAL
Intervention: Nitrendipine 10 mg given at 6 AM on awakening
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nitrendipine 10 mg given at 8:30 AM after breakfast
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nitrendipine 10 mg given at 6 PM after supper
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo during control period
Number of subjects: 6
Study: 2662394

Group type: EXPERIMENTAL
Intervention: Holte Sleeping Technique
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: COMPARATOR
Intervention: No-treatment
Number of subjects: 56
Study: 31339460

Group type: COMPARATOR
Intervention: Balance and motor control training (BMCT)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT)
Number of subjects: 71
Study: 30462198

Group type: EXPERIMENTAL
Intervention: Cryoablation with an 8 mm‐tip catheter (CRYO)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 158
Study: 26317176

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 237

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Both Varenicline and Placebo
Number of subjects: 237